
Sentix0.5 mg
Eskayef Bangladesh Ltd.
Flupentixol is a first-generation (typical) antipsychotic of the thioxanthene class.
Flupentixol is a first-generation (typical) antipsychotic of the thioxanthene class. Its use can be classified by strength of evidence as follows:
Flupentixol is not approved for the treatment of dementia-related psychosis in elderly patients. Antipsychotic medicines, including Flupentixol, are associated with an increased risk of death when used in elderly patients with dementia-related psychosis (see Precautions and Warnings).
Note: Flupentixol does not have marketing approval in the United States (no FDA/DailyMed listing); it is approved and used in the United Kingdom, European Union, Canada, Australia, and a number of countries in Asia and Africa, including Bangladesh.
| Indication | Formulation | Typical Dosing |
|---|---|---|
| Schizophrenia / chronic psychosis (acute or maintenance) | Oral tablets | Initial 3-9 mg/day, adjusted according to response; maintenance usually up to a maximum of 18 mg/day given once daily or in divided doses. Lower starting doses are used in elderly or debilitated patients. |
| Maintenance of schizophrenia (adherence difficulties) | Depot (decanoate) intramuscular injection | A small test dose (e.g., 20 mg) is often given first to assess tolerability, followed by maintenance doses typically in the range of 20-40 mg every 2-4 weeks, individualized and not usually exceeding 400 mg every 2 weeks. |
| Mild to moderate depressive symptoms (where regionally licensed) | Oral tablets, low dose | Typically 1 mg once or twice daily; treatment is generally short-term and reassessed if there is no improvement within a few weeks. |
Specific dose-adjustment guidelines are not well established; Flupentixol should be used cautiously and at lower doses in patients with significant hepatic or renal impairment, with close clinical monitoring.
Side effects of Flupentixol are generally dose-related.
| Frequency | Effects |
|---|---|
| Common | Extrapyramidal symptoms (tremor, rigidity, restlessness), sedation/drowsiness, insomnia, dizziness, headache, dry mouth, constipation, blurred vision, nausea, hyperprolactinemia (may cause menstrual irregularities, galactorrhea, sexual dysfunction), weight changes, sweating. |
| Uncommon | Orthostatic hypotension, palpitations, fainting, photosensitivity reactions. |
| Rare but serious | Neuroleptic malignant syndrome, tardive dyskinesia, QT interval prolongation/torsades de pointes, seizures, blood dyscrasias (leukopenia, agranulocytosis), liver function abnormalities/jaundice. |
Patients should seek prompt medical attention for high fever, severe muscle stiffness, confusion, irregular heartbeat, or involuntary movements while taking Flupentixol.
Flupentixol is contraindicated in patients with:
Flupentixol should also not be used in patients with pheochromocytoma or long QT syndrome, as these are established absolute contraindications for this agent. Other cautions (e.g., dementia-related psychosis, Parkinson's disease, hepatic/renal impairment) are addressed under Precautions and Warnings and do not constitute absolute contraindications.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.